Taysha Gene Therapies, Inc. Common Stock (NASDAQ: TSHA) last traded at $4.49, up 1.35% on the session. The quote above updates while this page is open; the figures below are drawn from Taysha Gene Therapies, Inc. Common Stock’s own filings and are restated only when a new one is published.
Taysha Gene Therapies, Inc. Common Stock trades on NASDAQ under the ticker TSHA. Its market capitalisation is $1.46 billion.
Valuation measures for Taysha Gene Therapies, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.46B |
|---|---|
| Enterprise value | $1.09B |
| Price / sales | 266.73 |
| Price / book | 3.78 |
| Beta | 1.74 |
Trailing-twelve-month figures tagged in Taysha Gene Therapies, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $5.49M |
|---|---|
| Net income (TTM) | -$149.63M |
| EPS (TTM) | -$0.420 |
| Operating margin | -2792.32% |
| Return on equity | -38.64% |
| Cash | $455.41M |
Range and volume for TSHA over the past 52 weeks.
| 52-week high | $7.30 |
|---|---|
| 52-week low | $3.69 |
| Volume | 5.38M |
| Average volume | 3.32M |
| Previous close | $4.43 |
Invest a chosen dollar amount in Taysha Gene Therapies, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TSHA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.